|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - UroGen Pharma Ltd. (URGN)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-09-04 Sale |
2019-09-06 09:27 am |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
343 | $33.92 | $11,635 | 6,350 (Direct) |
View |
| 2019-08-20 Sale |
2019-08-22 1:31 pm |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO |
1,416 | $33.07 | $46,827 | 8,333 (Direct) |
View |
| 2019-08-14 Sale |
2019-08-16 3:38 pm |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
608 | $31.65 | $19,243 | 10,555 (Direct) |
View |
| 2019-05-14 Sale |
2019-05-16 6:20 pm |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
608 | $37.98 | $23,092 | 12,314 (Direct) |
View |
| 2019-03-21 Purchase |
2019-03-22 7:42 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
272 | $37.01 | $10,066 | 4,610 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-07 9:46 pm |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,991 | $37.3 | $74,264 | 7,292 (Direct) |
View |
| 2019-02-14 Sale |
2019-03-07 9:44 pm |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
2,804 | $37.3 | $104,589 | 14,073 (Direct) |
View |
| 2017-11-27 Sale |
2017-11-29 5:07 pm |
UroGen Pharma Ltd. | URGN | ProQuest Investments IV L.P. ProQuest Associates IV LLC Moorin Jay SCHREIBER ALAIN 10% Owner |
209,298 | $40.6 | $8,497,871 | 1,419,838 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-09-04 Exercise |
2019-09-06 09:27 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,041 | $0 | 6,350 (Direct) |
View |
| 2019-09-04 Exercise |
2019-09-06 09:27 am |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,041 | $0 | 6,350 (Direct) |
View |
| 2019-08-20 Exercise |
2019-08-22 1:31 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO |
4,167 | $0 | 8,333 (Direct) |
View |
| 2019-08-20 Exercise |
2019-08-22 1:31 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO |
4,167 | $0 | 8,333 (Direct) |
View |
| 2019-08-14 Exercise |
2019-08-16 3:38 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
1,759 | $0 | 10,555 (Direct) |
View |
| 2019-08-14 Exercise |
2019-08-16 3:38 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
1,759 | $0 | 10,555 (Direct) |
View |
| 2019-06-04 Exercise |
2019-06-06 6:21 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,042 | $0 | 6,250 (Direct) |
View |
| 2019-06-04 Tax Withholding |
2019-06-06 6:21 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
343 | $35.05 | 6,250 (Direct) |
View |
| 2019-06-04 Exercise |
2019-06-06 6:21 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,042 | $0 | 6,250 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 5:02 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | Tomasello Shawn Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:59 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | FALBERG KATHRYN E Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:58 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:57 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:55 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | Nussbaum Ran Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:54 pm |
N/A 2019-06-02 |
UroGen Pharma Ltd. | URGN | Holden Stuart Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-06-03 Option Award |
2019-06-05 4:52 pm |
N/A 2029-06-02 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
10,000 | $34.83 | 10,000 (Direct) |
View |
| 2019-05-14 Exercise |
2019-05-16 6:20 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
1,759 | $0 | 12,314 (Direct) |
View |
| 2019-05-14 Exercise |
2019-05-16 6:20 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
1,759 | $0 | 12,314 (Direct) |
View |
| 2019-03-27 Exercise |
2019-03-28 4:52 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
128,000 | $4.02 | 212,211 (Direct) |
View |
| 2019-03-27 Exercise |
2019-03-28 4:52 pm |
N/A 2019-10-14 |
UroGen Pharma Ltd. | URGN | Belldegrun Arie Director |
128,000 | $4.02 | 212,211 (Direct) |
View |
| 2019-02-06 Exercise |
2019-03-22 7:41 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
15,000 | $16.99 | 25,000 (Direct) |
View |
| 2019-02-06 Exercise |
2019-03-22 7:41 pm |
N/A 2027-05-15 |
UroGen Pharma Ltd. | URGN | Cohen Fred E Director |
15,000 | $16.99 | 25,000 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-07 9:46 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,042 | $0 | 7,292 (Direct) |
View |
| 2019-03-04 Exercise |
2019-03-07 9:46 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
1,042 | $0 | 7,292 (Direct) |
View |
| 2019-02-14 Exercise |
2019-03-07 9:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
7,034 | $0 | 14,073 (Direct) |
View |
| 2019-02-14 Exercise |
2019-03-07 9:44 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
7,034 | $0 | 14,073 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:26 pm |
N/A 2029-01-26 |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
15,000 | $42.5 | 15,000 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:26 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Mullennix Stephen COO |
5,000 | $0 | 15,000 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:25 pm |
N/A 2029-01-26 |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO |
15,000 | $42.5 | 15,000 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:25 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | PFREUNDSCHUH PETER P. CFO |
5,000 | $0 | 15,000 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:24 pm |
N/A 2029-01-26 |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
7,500 | $42.5 | 7,500 (Direct) |
View |
| 2019-01-26 Option Award |
2019-01-29 5:24 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer |
2,500 | $0 | 7,500 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-09 8:25 pm |
N/A 2029-01-03 |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO |
277,432 | $47.57 | 317,065 (Direct) |
View |
| 2019-01-03 Option Award |
2019-01-09 8:25 pm |
N/A N/A |
UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. CEO |
317,065 | $0 | 317,065 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Fri, 20 Sep 2019 05:05:33 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |